These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 27178890

  • 1. Clinical benefits of aspirin desensitization in patients with nonsteroidal anti-inflammatory drug exacerbated respiratory disease are not related to urinary eicosanoid release and are accompanied with decreased urine creatinine.
    Makowska JS, Olszewska-Ziąber A, Bieńkiewicz B, Lewandowska-Polak A, Kurowski M, Woźniakowski B, Rotkiewicz A, Kowalski ML.
    Allergy Asthma Proc; 2016 May; 37(3):216-24. PubMed ID: 27178890
    [Abstract] [Full Text] [Related]

  • 2. Prostaglandin D₂: a dominant mediator of aspirin-exacerbated respiratory disease.
    Cahill KN, Bensko JC, Boyce JA, Laidlaw TM.
    J Allergy Clin Immunol; 2015 Jan; 135(1):245-52. PubMed ID: 25218285
    [Abstract] [Full Text] [Related]

  • 3. Sputum biomarkers during aspirin desensitization in nonsteroidal anti-inflammatory drugs exacerbated respiratory disease.
    Tyrak KE, Kupryś-Lipińska I, Czarnobilska E, Jakieła B, Pajdzik K, Ćmiel A, Plutecka H, Koziej M, Gawrońska A, Konduracka E, Kuna P, Sanak M, Mastalerz L.
    Respir Med; 2019 Jun; 152():51-59. PubMed ID: 31128610
    [Abstract] [Full Text] [Related]

  • 4. Eicosanoids, aspirin-intolerance and the upper airways--current standards and recent improvements of the desensitization therapy.
    Pfaar O, Klimek L.
    J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():5-13. PubMed ID: 17244950
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A comparative study of eicosanoid concentrations in sputum and urine in patients with aspirin-intolerant asthma.
    Higashi N, Taniguchi M, Mita H, Osame M, Akiyama K.
    Clin Exp Allergy; 2002 Oct; 32(10):1484-90. PubMed ID: 12372129
    [Abstract] [Full Text] [Related]

  • 10. Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study.
    Świerczyńska-Krępa M, Sanak M, Bochenek G, Stręk P, Ćmiel A, Gielicz A, Plutecka H, Szczeklik A, Niżankowska-Mogilnicka E.
    J Allergy Clin Immunol; 2014 Oct; 134(4):883-90. PubMed ID: 24767875
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Symptom Control of Patients With Chronic Rhinosinusitis With Nasal Polyps Under Maintenance Therapy With Daily Acetylsalicylic Acid.
    Hahn J, Appel H, Scheithauer MO, Petereit F, Greve J, Lindemann J, Hoffmann TK, Veit JA, Sommer F.
    Am J Rhinol Allergy; 2020 Jul; 34(4):554-563. PubMed ID: 32208749
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Safety and outcomes of aspirin desensitization for aspirin-exacerbated respiratory disease: A single-center study.
    Waldram J, Walters K, Simon R, Woessner K, Waalen J, White A.
    J Allergy Clin Immunol; 2018 Jan; 141(1):250-256. PubMed ID: 28550988
    [Abstract] [Full Text] [Related]

  • 17. The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases.
    Katial RK, Strand M, Prasertsuntarasai T, Leung R, Zheng W, Alam R.
    J Allergy Clin Immunol; 2010 Oct; 126(4):738-44. PubMed ID: 20728206
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Does aspirin therapy after desensitization still have a role in treatment of chronic rhinosinusitis with nasal polyposis in the era of biologics?].
    Klimek F, Förster-Ruhrmann U, Hagemann J, Cuevas M, Gröger M, Klimek L.
    HNO; 2024 Jul; 72(7):484-493. PubMed ID: 38409556
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms of Benefit with Aspirin Therapy in Aspirin-Exacerbated Respiratory Disease.
    Hill J, Burnett T, Katial R.
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):735-747. PubMed ID: 27712767
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.